ArticleBMJ open2022

Qualitative study exploring the experiences and perceptions of dolutegravir/lamivudine dual antiretroviral therapy (the PEDAL study) in people living with HIV: protocol.

Giovanni Villa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.